Company: KNRX
Filing Date: 2025-03-05
Form Type: F-1/A
Source: 0001493152-25-009104
Chunk: 153

Company: KNOREX LTD.
Filing Date: 2025-03-05
Form: F-1/A
Chunk 153
---
 is                                                                                         
 not required to open its register of members for inspection;                               |
| ● | does                                                                                       
 not have to hold an annual general meeting;                                                |
| ● | may                                                                                        
 obtain an undertaking against the imposition of any future taxation (such undertakings are 
 usually given for 20 years in the first instance);                                         |
| ● | may                                                                                        
 register by way of continuation in another jurisdiction and be deregistered in the Cayman  
 Islands;                                                                                   |
| ● | may                                                                                        
 register as a limited duration company; and                                                |
| ● | may                                                                                        
 register as a segregated portfolio company.                                                |

| 80 |

Warrants

Pursuant to the Restructuring
Agreement, the Company issued warrants on September 30, 2024 to shareholders of the Company, who were previously shareholders of Knorex
SG, and certain other persons in exchange for warrants previously issued to them by Knorex SG. The warrants issued by the Company included:
(i) a total of 4,692,100 warrants with an aggregate amount of US$7,722,941 and (ii) a set of warrants with an aggregate amount of US$836,597,
both exercisable for the same type of securities the Company issues in its next immediate equity financing round that involves the issuance
of preference shares or preferred securities in the Company to raise funds for the Company (or Class A Ordinary Shares if such immediate
equity financing round is our Company’s initial public offering). The expiration dates of the warrants range from December 2024
to December 2026. In January 2025, a total of 164,713 warrants described in (i) above were exercised to subscribe for 164,713 Class A
Ordinary Shares with the remaining 4,527,387 warrants been cancelled in exchange for the issuance of a total of 4,527,387 warrants with
an aggregate amount of US$7,073,397.74 to extend the expiration dates to a period range from March 2026 to December 2027. The exercise
price for the warrants described in (ii) above with an aggregate amount of US$836,597 shall be determined by reference to the issue price
of the types of securities and shall be equal to the issue price of the securities being offered in the next immediate equity funding
round (or equal to 65% of the issue price of Class A Ordinary Shares if the next immediate equity funding round is the Company’s
initial